Menora Mivtachim Holdings’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$353M Buy
294,200
+400
+0.1% +$409K 1.38% 17
2026
Q1
$270M Hold
293,800
1.28% 19
2025
Q4
$316M Hold
293,800
1.48% 18
2025
Q3
$224M Buy
293,800
+47,500
+19% +$35.3M 1.14% 30
2025
Q2
$192M Hold
246,300
1.1% 31
2025
Q1
$203M Buy
246,300
+32,400
+15% +$27M 1.32% 25
2024
Q4
$165M Sell
213,900
-32,968
-13% -$27.3M 1.04% 32
2024
Q3
$219M Buy
+246,868
New +$222M 1.38% 28

Other funds holding LLY

Menora Mivtachim Holdings's LLY Position: Q2 2026 in Review

Menora Mivtachim Holdings increased its Eli Lilly (LLY) stake by 0.14% in Q2 2026, buying an estimated $409K and bringing the position to 294,200 shares worth $353M. The position accounts for 1.38% of the portfolio, ranked #17.

Menora Mivtachim Holdings first reported a position in LLY in Q3 2024 and has held it in 8 quarters since. 4,626 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Menora Mivtachim Holdings held 294,200 shares of Eli Lilly worth $353M as of Q2 2026.
  • Menora Mivtachim Holdings bought 400 Eli Lilly shares in Q2 2026, an estimated $409K.
  • Eli Lilly made up 1.38% of Menora Mivtachim Holdings's portfolio in Q2 2026, its #17 holding.
  • Menora Mivtachim Holdings first reported a position in Eli Lilly in Q3 2024 and has held it in 8 quarters since.
  • 4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Menora Mivtachim Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.